Influence of fines on the surface energy heterogeneity of lactose for pulmonary drug delivery

被引:28
作者
Ho, Raimundo [1 ]
Muresan, Adrian S. [2 ]
Hebbink, Gerald A. [3 ]
Heng, Jerry Y. Y. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, Surfaces & Particle Engn Lab, London SW7 2AZ, England
[2] FrieslandCampina Res, NL-7418 BA Deventer, Netherlands
[3] FrieslandCampina DOMO, NL-8017 JD Zwolle, Netherlands
关键词
Carrier particle; Lactose; Pulmonary drug delivery; Inverse gas chromatography; Surface energy; POWDER INHALATION FORMULATIONS; PARTICLE-SIZE; CARRIER; CRYSTALLIZATION; DISTRIBUTIONS; PERFORMANCE; DISPERSION; MIXTURES;
D O I
10.1016/j.ijpharm.2009.12.037
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of the blending of lactose fines to the overall adhesion property of coarse alpha-lactose monohydrate carrier particles were investigated. Five samples, three of them commercial samples from DOMO (Lactohale (R) LH100, LH210, and LH250) whilst the other two are blends of LH210 and LH250, were studied. Characterisation included particle sizing, SEM, PXRD and IGC. Dispersive surface energy gamma(d)(SV) was determined using a finite concentration IGC method to obtain a distribution profile. The gamma(d)(SV) distribution of lactose crystals was found to vary from 40 to 48 mJ/m(2). The unmilled coarse crystalline lactose sample (LH100) gamma(d)(SV) was lowest and showed less heterogeneity than the milled sample (LH250). Fines (LH210) were found to have the highest gamma(d)(SV) value. The samples with loaded LH210 were found to have a higher energy than LH100. The amount of LH210 in Blend I was not able to decrease surface energy heterogeneity, whereas sample Blend 2 showed adequate loading of fines to obtain a relatively homogeneous surface. Addition of fines resulted in an increase in gamma(d)(SV) suggesting that coarse lactose surfaces were replaced by surfaces of the fines. Increasing the loading of fines may result in a more homogeneous surface energy of lactose particles. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:88 / 94
页数:7
相关论文
共 19 条
[11]   The bulk crystallization of α-lactose monohydrate from aqueous solution [J].
Raghavan, SL ;
Ristic, RI ;
Sheen, DB ;
Sherwood, JN .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (07) :823-832
[12]   THE ROLE OF THE INTERFACE IN CARBON-FIBER EPOXY COMPOSITES [J].
SCHULTZ, J ;
LAVIELLE, L ;
MARTIN, C .
JOURNAL OF ADHESION, 1987, 23 (01) :45-60
[13]   The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations [J].
Shur, Jagdeep ;
Harris, Haggis ;
Jones, Matthew D. ;
Kaerger, J. Sebastian ;
Price, Robert .
PHARMACEUTICAL RESEARCH, 2008, 25 (07) :1931-1940
[14]   Determination of the surface energy distributions of different processed lactose [J].
Thielmann, Frank ;
Burnett, Daniel J. ;
Heng, Jerry Y. Y. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (11) :1240-1253
[15]   DRUG-DELIVERY TO THE RESPIRATORY-TRACT USING DRY POWDER INHALERS [J].
TIMSINA, MP ;
MARTIN, GP ;
MARRIOTT, C ;
GANDERTON, D ;
YIANNESKIS, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 101 (1-2) :1-13
[16]   Predicting the aerosol performance of dry powder inhalation formulations by interparticulate interaction analysis using inverse gas chromatography [J].
Tong, HHY ;
Shekunov, BY ;
York, P ;
Chow, AHL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (01) :228-233
[17]   Inverse gas chromatographic method for measuring the dispersive surface energy distribution for particulates [J].
Yla-Maihaniemi, Pirre P. ;
Heng, Jerry Y. Y. ;
Thielmann, Frank ;
Williams, Daryl R. .
LANGMUIR, 2008, 24 (17) :9551-9557
[18]   The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols [J].
Zeng, XM ;
Pandhal, KH ;
Martin, GP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 197 (1-2) :41-52
[19]   Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation [J].
Zeng, XM ;
Martin, GP ;
Tee, SK ;
Abu Ghoush, A ;
Marriott, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (02) :133-144